Gerald Blumenstock Sells Axcelis Technologies Shares

Gerald Blumenstock, Executive Vice President of Research, Development & Engineering at Axcelis Technologies, Inc. (NasdaqGS: ACLS), sold 506 shares of the company's stock on June 15, 2026. The shares were sold at an average price of $191.60 each, totaling approximately $96,949.60. This transaction was not part of a pre-planned trading program.

Insider Buying and Selling at Axcelis Technologies, Inc.

Several other insiders at Axcelis Technologies have also sold shares recently. Necip Sayiner sold 1,586 shares on June 3, 2026, at $157.44 each. Robert John Mahoney, EVP of Global Operations, sold 1,155 shares on June 2, 2026, at $155.24 per share. VP Corporate Controller Todd Sutton sold 2,000 shares on May 27, 2026, at $159.99 each. Lastly, Thomas St. Dennis and EVP Eileen Evans sold 900 and 926 shares, respectively, on May 22, 2026, at prices around $155.50.

Other Institutional Activity in Axcelis Technologies

Institutional investors have been active in Axcelis Technologies. BlackRock, Inc. increased its holdings by 109,199 shares, bringing its total to 4,936,774 shares valued at about $459.5 million. FMR LLC significantly boosted its position by 1,820,518 shares, holding 2,431,121 shares worth roughly $226.3 million. Reinhart Partners, LLC also added 67,847 shares, totaling 1,657,745 shares valued at approximately $154.3 million.

Axcelis Technologies, Inc. Stock Up 56.1%

Shares of Axcelis Technologies are trading around $188.60. The company has a market cap of about $5.89 billion and a P/E ratio of 59.5. Its forward P/E stands at 41.3, with a beta of 1.918, indicating higher volatility compared to the market. The 52-week range for the stock is between $64.62 and $193.78, with a 50-day moving average of $144.48 and a 200-day moving average of $101.10. Axcelis maintains strong liquidity with a current ratio of 4.59 and a quick ratio of 2.59, alongside a debt-to-equity ratio of 6.75.

Recent Earnings

In its latest earnings report, Axcelis Technologies posted revenue of $845.4 million, reflecting a growth rate of 3.3%. The company achieved a net margin of 11.93% and a return on equity of 9.74%. Earnings per share were $3.22. Axcelis is expected to release its next earnings report on August 4, 2026.

Analysts Set New Price Targets

Analysts have set new price targets for Axcelis Technologies. On February 18, 2026, B. Riley Securities maintained a 'hold' rating with a $91.00 price target. B of A Securities downgraded the stock to a 'sell' on January 13, 2026, setting a target of $100.00. DA Davidson, on October 2, 2025, maintained a 'buy' rating with a $110.00 target.

About Axcelis Technologies

Axcelis Technologies, Inc. designs and manufactures equipment used in the production of semiconductor chips. The company provides ion implantation and other processing equipment to semiconductor manufacturers in the U.S., Europe, and Asia Pacific. Headquartered in Beverly, Massachusetts, Axcelis employs about 1,465 people and is led by CEO Dr. Russell J. Low.

Bottom Line

Gerald Blumenstock's recent sale of Axcelis Technologies shares is part of a broader trend of insider selling at the company. Investors often watch insider transactions closely, though these sales do not necessarily indicate negative sentiment. Institutional activity shows continued interest in the company, with major funds increasing their stakes. Remember, 13F filings and insider transactions are historical and may not reflect current positions or intentions.